Alnylam price target raised to $385 from $384 at Canaccord
Canaccord analyst Whitney Ijem raised the firm’s price target on Alnylam (ALNY) to $385 from $384 and keeps a Buy rating on the shares. The ...
Alnylam Delivers a Big Q4 Earnings Beat
Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported ...
How the owner of Rebelle in Kendall Square traded in beakers for bagels
When Milena Pagán graduated from MIT as a chemical engineer, she tried consulting, but it left her unfulfilled. “I was just ...
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $284.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target upped by Morgan Stanley from $275.00 to $284.00 in a research note issued to investors on Friday,Benzinga reports. Morgan ...
Alnylam Pharmaceuticals’ (ALNY) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report published on Friday morning,Benzinga reports. They ...
Alnylam price target lowered to $300 from $310 at Scotiabank
Scotiabank lowered the firm’s price target on Alnylam (ALNY) to $300 from $310 and keeps an Outperform rating on the shares. The firm is ...
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Shares of Charles River Laboratories International Inc. advanced 6.87% to $165.00 Wednesday, on what proved to be an ...
American Century Focused Dynamic Growth Fund Q4 2024 Commentary
The reelection of former President Donald Trump initially pleased investors who had worried about another protracted legal ...